Remarkably, we found that TLS led to an increase in the antitumour effect by recruiting CD8<sup>+</sup> T cells in HNSCC, showing a CD8<sup>+</sup> T-cell-dependent antitumour effect. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.